
Genetically Engineered Insulin may CAUSE Diabetes Type 1 in Type 2 Diabetics
Just when you think GMO crops have caused enough damage as possible, there’s a new study proving their munificence to a deeper level. A new study shows that GE-created synthetic insulin could actually cause Diabetes Type 1 in Type 2 diabetics. Thank you biotech industry for creating a potentially new way to get diabetes.
The study, published in the Journal of Clinical Endocrinology & Metabolism and titled “Insulin administration may trigger type 1 diabetes in Japanese type 2 diabetes patients with type 1 diabetes high-risk HLA class II and the insulin gene VNTR genotype,” is posing a possible explanation for why insulin treatment may accelerate morbidity and mortality in Type 2 diabetics.
The research showed that administering genetically susceptible Type 2 diabetes patients with recombinant insulin can trigger their bodies to target their own insulin, producing cells for autoimmune destruction and effectively producing ‘double diabetes’: Type 1 and Type 2, as a result.
Recombinant refers to anything that is inserted with foreign DNA (molecular cloning or genetic alteration) to make a new sequence. Insulin is no different. Our bodies already make their own natural insulin, but in diabetes Type 2 patients, their pancreatic secretions are not sufficient to make enough insulin and glucagon, and therefore they end up taking insulin to balance their sugar levels.
The Study
The latest study pointing to GMO insulin as the culprit in creating diabetes Type 1 took 6 patients (4 men and 2 women) in Japan with diabetes Type 2, all whom had not previously received insulin the
Continue
reading